Russia has announced the creation of a vaccine that "dissolves" metastases in cancer patients.
The head of the Gamaliya Center, which is subordinate to the Ministry of Health of the Russian Federation, Alexander Gintsburg, said in an interview with Gazeta. Ru" that the oncological vaccine developed in Russia caused the disappearance of metastases in a cancer patient. According to Gunzburg, this happened in the first patient with melanoma who received the personal vaccine Neonkovak, which was developed at the Gamaliya Center.
In response to the reporter's clarification question as to whether the patient's metastases had disappeared, Gunzburg confirmed: "Yes, they have disappeared."
According to him, the first patient is now under monthly follow-up, and so far five other patients have received the vaccine. The second patient is about halfway through the course and is tolerating the treatment better than the first; He doesn't even have a low fever. By the end of the year, scientists plan to treat 20 people at the Harzan Institute.